好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

SCN2A Related Early Onset Epileptic Encephalopathy Responsive to Phenobarbital
Child Neurology and Developmental Neurology
(-)
231
Authors/Disclosures
Fiona M. Baumer, MD (Stanford University School of Medicine; Lucile Packard Children'S Hospital)
PRESENTER
Dr. Baumer has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Curtis & Co. Dr. Baumer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Cades Schutte LLP. An immediate family member of Dr. Baumer has stock in Apple (Apple Watch is wearable). An immediate family member of Dr. Baumer has stock in Google (owns Fitbit). The institution of Dr. Baumer has received research support from NINDS. The institution of Dr. Baumer has received research support from Doris Duke/Rita Allen Foundation. The institution of Dr. Baumer has received research support from Pediatric Epilepsy Research Foundation. The institution of Dr. Baumer has received research support from Stanford University. Dr. Baumer has received personal compensation in the range of $0-$499 for serving as a Presenter; honorarium with AES. Dr. Baumer has received personal compensation in the range of $0-$499 for serving as a Presenter; honorarium with ACNS. Dr. Baumer has received personal compensation in the range of $0-$499 for serving as a Teacher at TMS-EEG Science Course; honorarium with Aalto University (Finland).
Jurriaan Peters, MD (Boston Childrens Hospital) Dr. Peters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. Dr. Peters has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Peters has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for CRICO. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for UCB.
Christelle M. Achkar, MD Dr. Achkar has nothing to disclose.
PHILLIP L. PEARL, MD, FAAN (Boston Children'S Hospital) Dr. Pearl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Pearl has received publishing royalties from a publication relating to health care. Dr. Pearl has received publishing royalties from a publication relating to health care. Dr. Pearl has received publishing royalties from a publication relating to health care. Dr. Pearl has received publishing royalties from a publication relating to health care.
Philip De Jager, MD, PhD (Columbia University Irving Medical Center) Dr. De Jager has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Puretech. Dr. De Jager has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for roche. Dr. De Jager has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. The institution of Dr. De Jager has received research support from roche. The institution of Dr. De Jager has received research support from puretech.